版本:
中国

BRIEF-BEIGENE INITIATES FIRST PIVOTAL STUDY IN CHINA OF PD-1 ANTIBODY BGB-A317

April 21 Beigene Ltd

* BEIGENE ANNOUNCES INITIATION OF FIRST PIVOTAL STUDY IN CHINA OF PD-1 ANTIBODY BGB-A317

* SAYS ALSO PLAN TO INITIATE STUDIES TO ENABLE REGULATORY APPROVAL OF BGB-A317 IN MULTIPLE GEOGRAPHIES OUTSIDE OF CHINA Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐